A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in the CDKN2 Tumor-Suppressor Gene

  • Whelan A
  • Bartsch D
  • Goodfellow P
245Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

Abstract

The distinguishing characteristics of familial cancer syndromes are an inherited predisposition to one or more characteristic types of tumors, early age at onset, and multiple synchronous or asynchronous tumors. Recently, the genes responsible for a number of inherited cancers have been identified. 1 – 5 We describe a kindred with an increased risk of pancreatic cancers, melanomas, and possibly additional types of tumors. We provide strong evidence linking the predisposition to cancer in this kindred to an inherited mutation in the cyclin-dependent–kinase inhibitor 2 (CDKN2) tumor-suppressor gene. The results of our study of this family suggest that disruption of the. © 1995, Massachusetts Medical Society. All rights reserved.

Cite

CITATION STYLE

APA

Whelan, A. J., Bartsch, D., & Goodfellow, P. J. (1995). A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in the CDKN2 Tumor-Suppressor Gene. New England Journal of Medicine, 333(15), 975–977. https://doi.org/10.1056/nejm199510123331505

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free